68 search results
- Current search:
- Childhood Cancer
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
TitlePublished 16 Jul 2017
Physical and psychological interventions for cancer-related pain in children with cancer
Childhood Cancer Group Erik Loeffen Title Tuesday, July 11, 2017 ... -
TitlePublished 16 Jul 2017
Physical and psychological interventions for procedural pain in children with cancer
Childhood Cancer Group Erik Loeffen Title Tuesday, July 11, 2017 ... -
TitlePublished 16 Jul 2017
Pharmacological interventions for bone pain in children with cancer
Childhood Cancer Group Erik Loeffen Title Tuesday, July 11, 2017 ... -
TitlePublished 16 Jul 2017
Pharmacological interventions for chemotherapy-induced neuropathic pain in children with cancer
Childhood Cancer Group Erik Loeffen Title Tuesday, July 11, 2017 ... -
TitlePublished 16 Jul 2017
Pharmacological interventions for procedural pain in children with cancer
Childhood Cancer Group Erik Loeffen Title Tuesday, July 11, 2017 ... -
TitlePublished 16 Jul 2017
Pharmacological interventions for anti-GD2 antibody infusion related pain in children with cancer
Childhood Cancer Group Erik Loeffen Title Tuesday, July 11, 2017 ... -
TitlePublished 18 Jun 2017
Haploidentical haematopoietic stem cell transplantation (haplo-HSCT) for Acute myeloid leukemia (AML) in children
Childhood Cancer Group Poh Lin Tan Title Tuesday, June 13, 2017 ... -
NewCochrane EvidencePublished 13 Jun 2017
Severe fatigue in childhood cancer survivors
Protocol: The main objective is to estimate the prevalence of severe fatigue, as part of the cancer-related fatigue (CRF) definition, in childhood cancer survivors (CCS). The second objective is to describe the course of severe fatigue following cancer treatment and examine risk factors for, or factors associated with, severe fatigue (e.g. ... -
NewCochrane EvidencePublished 7 Jun 2017
Focal laser treatment in addition to chemotherapy for retinoblastoma
What was the aim of this review? The aim of this Cochrane Review was to find out if focal laser therapy in addition to treatment by systemic chemotherapy for retinoblastoma reduces the risk of tumour recurrence. Key messages There were no data comparing systemic chemotherapy alone to systemic chemotherapy with laser therapy. What was studied in the ... -
Cochrane EvidencePublished 21 Apr 2017
Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma
Review question We reviewed the evidence of the effectiveness and side effects of 131I-meta-iodobenzylguanidine (131I-MIBG) therapy in patients with newly diagnosed high-risk (HR) neuroblastoma (NBL). Background NBL is a rare solid cancer that develops from special nerves cells. Patients with newly diagnosed HR NBL have a poor outcome, despite intensive ...